Colin Giles

Colin Giles is the Chief Development Officer at Invetx. He's passionate about bringing Invetx’s portfolio of innovative veterinary biotherapeutics through the regulatory process to be available to practicing veterinarians and their patients. Colin has 35 years of experience in the management of R&D in the Animal Health Industry including many years in senior leadership positions; focused on bringing innovative veterinary medicines to the marketplace.

Colin holds a BVetMed and a Ph.D. from Royal Veterinary College, University of London, UK.